日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer.

TROP2/claudin 程序介导免疫排斥,从而阻碍乳腺癌中的检查点阻断。

Wu Bogang, Thant Win, Bitman Elena, Liu Ting, Liu Jie, Paschalis Eleftherios I, Patel Bidish K, Nawrocki Cole, Xu Katherine H, Nieman Linda T, Ting David T, de Gois Macedo Bruna, Cheng Yang, Jiang Kevin, Sun Fengfei, Thimmiah Nayana, Sun Sheng, Abelman Rachel O, Bossuyt Veerle I, Isakoff Steven J, Spring Laura M, Bardia Aditya, Ellisen Leif W

Breast cancer inequities: the intersectional role of social epidemiology and tumor biology

乳腺癌不平等:社会流行病学和肿瘤生物学的交叉作用

Peiris, Malalage Nicole; Dedeoglu, Aylin; Smidt, Ilze; Suzuki, Akiko; Rheinbay, Esther; Ilinski, Adrian; Chen, Jiaji George; Imafidon, Osasogie; Ennis, Christina; Mahdaviani, Kiana; Dries, Ruben; Ellisen, Leif W; Ko, Naomi Y

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.

从临床到实验室的转化分析:激素受体阳性转移性乳腺癌中 NF1 改变和 CDK4/6 抑制剂耐药性

Lloyd Maxwell R, Chica-Parrado Rosario, Weipert Caroline M, Knepper Todd C, Podany Emily L, Napolitano Fabiana, Ye Dan, Lin Chang-Ching, Uemoto Yasuaki, Liao Jiemin, Wegrzyn Claire, Walko Christine M, Ryan Lianne Y, Keenan Jennifer C, Medford Arielle J, Liu Shiyuan A, Wulf Gerburg M, Clifton Katherine K, Ma Cynthia X, Han Hyo S, Zhang Nicole, Ellisen Leif W, Bardia Aditya, Arteaga Carlos L, Hanker Ariella B, Wander Seth A

TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

转移性乳腺癌患者中TOP1突变和抗体药物偶联物的交叉耐药性

Abelman Rachel O, Wu Bogang, Barnes Haley, Medford Arielle, Norden Bryanna, Putur Annika, Bitman Elena, Thant Win, Liu Ting, Weipert Caroline, Fell Geoffrey, Spring Laura M, Wander Seth A, Moy Beverly, Vidula Neelima, Isakoff Steven J, Varkaris Andreas, Juric Dejan, Corcoran Ryan B, Ellisen Leif W, Bardia Aditya

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)

使用细胞周期蛋白依赖性激酶 4/6 抑制剂 ribociclib 进行辅助内分泌治疗,用于治疗局部激素受体阳性/HER2- 乳腺癌(LEADER)

Spring, Laura M; Scarpetti, Lauren; Medford, Arielle J; Niemierko, Andrzej; Comander, Amy; Mulvey, Therese; Schnipper, Lowell; Isakoff, Steven J; Moy, Beverly; Wander, Seth A; Shin, Jennifer; Ephrem, Zanta; Laposta, Anneke R; Denault, Elyssa; Abraham, Elizabeth; Calistro, Gayle; Kalashnikova, Ekaterina; Rodriguez, Angel; Liu, Minetta C; Aleshin, Alexey; Peppercorn, Jeffrey; Ellisen, Leif W; Bardia, Aditya

Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies

三阴性乳腺癌(TNBC)患者中HER2低表达状态的动态变化及其对重复活检的影响

Bar, Yael; Fell, Geoffrey; Dedeoglu, Aylin; Moffett, Natalie; Vidula, Neelima; Spring, Laura; Wander, Seth A; Bardia, Aditya; Ko, Naomi; Moy, Beverly; Ellisen, Leif W; Isakoff, Steven J

Selection biases in the systematic collection of breast biobank specimens

系统性收集乳腺生物样本库标本中的选择偏差

Bar, Yael; Wang, Gary X; Gioia, Gabrielle E; Fell, Geoffrey; Chou, Shinn-Huey S; Bossuyt, Veerle; Isakoff, Steven J; Moy, Beverly; Ellisen, Leif W; Lehman, Constance D; Spring, Laura M

Current landscape of sequencing ADCs in metastatic breast cancer

转移性乳腺癌中抗体药物偶联物(ADC)测序的现状

McLaughlin, Shannon; Ravani, Lis V; Moy, Beverly; Medford, Arielle J; Isakoff, Steven J; Liu, Ting; Ellisen, Leif W; Spring, Laura M; Wander, Seth A; Abelman, Rachel O

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes

GATA3突变转移性激素受体阳性乳腺癌的基因组和蛋白质组分析及其对临床结果的影响

Medford, Arielle J; Velimirovic, Marko; Gefen, Yifat; Niemierko, Andrzej; Gerratana, Lorenzo; Davis, Andrew A; Clifton, Katherine; Keenan, Jennifer; Podany, Emily; Hensing, Whitney L; Reduzzi, Carolina; Dai, Charles S; Kiedrowski, Lesli A; Spring, Laura M; Ellisen, Leif W; Doebele, Robert C; Cristofanilli, Massimo; Getz, Gad; Bardia, Aditya

Author Correction: Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair

作者更正:减数分裂蛋白SYCP2通过R环介导的DNA修复赋予细胞对DNA损伤剂的抵抗力。

Wang, Yumin; Gao, Boya; Zhang, Luyuan; Wang, Xudong; Zhu, Xiaolan; Yang, Haibo; Zhang, Fengqi; Zhu, Xueping; Zhou, Badi; Yao, Sean; Nagayama, Aiko; Lee, Sanghoon; Ouyang, Jian; Koh, Siang-Boon; Eisenhauer, Eric L; Zarrella, Dominique; Lu, Kate; Rueda, Bo R; Zou, Lee; Su, Xiaofeng A; Yeku, Oladapo; Ellisen, Leif W; Wang, Xiao-Song; Lan, Li